About: The influence of the SARS-CoV-2 pandemic on esophagogastric cancer services: an international survey of esophagogastric surgeons

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: The influence of the SARS-CoV-2 pandemic on esophagogastric cancer services: an international survey of esophagogastric surgeons Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	The influence of the SARS-CoV-2 pandemic on esophagogastric cancer services: an international survey of esophagogastric surgeons
Creator	Griffiths, Ewen Kamarajah, Sivesh Markar, Sheraz Singh, Pritam Anastomosis, Oesophagogastric Group, Audit
Source	Medline; PMC
abstract	BACKGROUND: Several guidelines to guide clinical practice among esophagogastric surgeons during the COVID-19 pandemic were produced. However, none provide reflection of current service provision. This international survey aimed to clarify the changes observed in esophageal and gastric cancer management and surgery during the COVID-19 pandemic. METHODS: An online survey covering key areas for esophagogastric cancer services, including staging investigations and oncological and surgical therapy before and during (at two separate time-points—24th March 2020 and 18th April 2020) the COVID-19 pandemic were developed. RESULTS: A total of 234 respondents from 225 centers and 49 countries spanning six continents completed the first round of the online survey, of which 79% (n = 184) completed round 2. There was variation in the availability of staging investigations ranging from 26.5% for endoscopic ultrasound to 62.8% for spiral computed tomography scan. Definitive chemoradiotherapy was offered in 14.8% (adenocarcinoma) and 47.0% (squamous cell carcinoma) of respondents and significantly increased by almost three-fold and two-fold, respectively, in both round 1 and 2. There were uncertainty and heterogeneity surrounding prioritization of patients undergoing cancer resections. Of the surgeons symptomatic with COVID-19, only 40.2% (33/82) had routine access to COVID-19 polymerase chain reaction testing for staff. Of those who had testing available (n = 33), only 12.1% (4/33) had tested positive. CONCLUSIONS: These data highlight management challenges and several practice variations in caring for patients with esophagogastric cancers. Therefore, there is a need for clear consistent guidelines to be in place in the event of a further pandemic to ensure a standardized level of oncological care for patients with esophagogastric cancers.
has issue date	2020-06-05(xsd:dateTime)
bibo:doi	10.1093/dote/doaa054
bibo:pmid	32500134
has license	no-cc
sha1sum (hex)	fd35896f72ce6891551135f445d508b115c943f4
schema:url	https://doi.org/10.1093/dote/doaa054
resource representing a document's title	The influence of the SARS-CoV-2 pandemic on esophagogastric cancer services: an international survey of esophagogastric surgeons
has PubMed Central identifier	PMC7314222
has PubMed identifier	32500134
schema:publication	Dis Esophagus
resource representing a document's body	covid:fd35896f72ce6891551135f445d508b115c943f4#body_text
is schema:about of	named entity 'There' named entity 'tested' named entity 'total' named entity 'service provision' named entity 'investigations' named entity 'Background' named entity '225' named entity 'SURVEY' named entity 'METHODS' named entity '184' named entity 'PRACTICE' named entity 'CELL' named entity 'THESE' named entity 'ESOPHAGEAL' named entity 'PLACE' named entity 'APRIL' named entity 'cancer' named entity 'respondents' named entity 'clear' named entity 'clarify' named entity 'respondents' named entity 'caring' named entity 'squamous cell carcinoma' named entity 'cancer' named entity 'spanning' named entity 'COVID-19' named entity 'level' named entity 'COVID-19' named entity 'surgeons' named entity 'COVID-19' named entity 'clinical practice' named entity 'cancer' named entity 'There' named entity 'oncological' named entity 'tumor board' named entity 'surgical intervention' named entity 'interquartile range' named entity 'bronchoscopy' named entity 'self-isolate' named entity 'neoadjuvant' named entity 'chi-squared test' named entity 'Non-normally distributed' named entity 'sample size' named entity 'pneumonia' named entity 'endoscopic ultrasound' named entity 'COVID-19' named entity 'COVID-19' named entity 'SARS-CoV-2' named entity 'Corona Virus' named entity 'neoadjuvant therapy' named entity 'surgical resection' named entity 'laparoscopy' named entity 'influenza pandemic' named entity 'neoadjuvant therapy' named entity 'multidisciplinary team' named entity 'neoadjuvant' named entity 'gastric cancers' named entity 'COVID-19' named entity 'healthcare professionals' named entity 'spiral CT scan' named entity 'oncological' named entity 'HDU' named entity 'resections' named entity 'MDT' named entity 'palliation' named entity 'triage' named entity 'viral load' named entity 'COVID-19' named entity 'esophageal squamous cell carcinoma' named entity 'H1N1' named entity 'MDT' named entity 'emergency department' named entity 'National Health Service England' named entity 'oncological' named entity 'randomized trial' named entity 'COVID-19 pandemic'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software